With eyes on Gilead, lawmakers want details on how HHS reviews possible patent infringement

After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.
Source: Alex Wong/Getty Images

A pair of lawmakers has asked the Government Accountability Office to review how the U.S. Department of Health and Human Services manages patents and licenses for medicines that were discovered, at least in part, with taxpayer dollars.

The move by Sen. Debbie Stabenow (D-Mich.) and Rep. Elijah Cummings (D-Md.) follows a ruckus over a pricey Gilead Sciences () pill for treating and preventing HIV and the role federal government may have played in discovering the medicine, which is

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readPsychology
It’s Not Just Bosses Who Harass Health Workers: Hospitals Start Addressing Patients’ ‘Egregious’ Behavior
There's growing awareness that it’s not just bosses and colleagues who sexually harass health care workers. Often, it’s the patients who are doing the harassing.
STAT5 min readPolitics
Opinion: Wider Use Of Assisted Outpatient Treatment Could Help Individuals With Mental Illness
Many states still rely on laws that require individuals to become dangerous to themselves or others before they can be treated without their consent. We need laws that that prevent…
STAT9 min readWellness
‘The Switch’ Was Supposed To Be A Major Step Toward Eradicating Polio. Now It’s A Quandary
A change in polio vaccination policies was supposed to put the world on a better footing to finally eliminate a global scourge. It's gotten complicated.